> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Vita Medical ‘Spray-on Skin Cells’ Approved for Burns
- URL: https://www.fdaweb.com/vita-medical-spray-on-skin-cells-approved-for-burns/
- Published: 2018-09-21T12:00:00.000Z
- Updated: 2026-09-15T00:33:25.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5142417

FDA has approved a Vita Medical PMA for the Recell Autologous Cell Harvesting Device for treating severe thermal burns in patients 18 years and older. The device uses a small amount of a patient’s own skin to prepare “spray-on skin cells” at the point of care in as little as 30 minutes, the company says. Approval was based on data from two randomized, controlled clinical trials that demonstrated that treatment of acute burn wounds with the Recell system required substantially less donor skin than required with conventional split-thickness autografts to achieve burn wound closure, Vita Medical says.

  
The device, the company says, can be used alone in treating partial-thickness burns, or in combination with autografting for full-thickness burns. A small skin sample is collected and immersed in its proprietary enzyme solution in the Recell system to separate the skin cells to produce spray-on skin cells. “The resultant regenerative epidermal suspension includes keratinocytes, fibroblasts, and melanocytes, which play a critical role in wound healing,” it says. “The suspension is then sprayed directly onto the prepared burn wound, providing a broad and even distribution of live cells across the entire wound bed.”